178 related articles for article (PubMed ID: 21831731)
21. Stable low-level expression of p21WAF1/CIP1 in A549 human bronchogenic carcinoma cell line-derived clones down-regulates E2F1 mRNA and restores cell proliferation control.
Graves TG; Harr MW; Crawford EL; Willey JC
Mol Cancer; 2006 Jan; 5():1. PubMed ID: 16403226
[TBL] [Abstract][Full Text] [Related]
22. microRNA-16-5p enhances radiosensitivity through modulating Cyclin D1/E1-pRb-E2F1 pathway in prostate cancer cells.
Wang F; Mao A; Tang J; Zhang Q; Yan J; Wang Y; Di C; Gan L; Sun C; Zhang H
J Cell Physiol; 2019 Aug; 234(8):13182-13190. PubMed ID: 30536619
[TBL] [Abstract][Full Text] [Related]
23. E2F-1, Skp2 and cyclin E oncoproteins are upregulated and directly correlated in high-grade neuroendocrine lung tumors.
Salon C; Merdzhanova G; Brambilla C; Brambilla E; Gazzeri S; Eymin B
Oncogene; 2007 Oct; 26(48):6927-36. PubMed ID: 17471231
[TBL] [Abstract][Full Text] [Related]
24. Cell cycle deregulation in liver lesions of rats with and without genetic predisposition to hepatocarcinogenesis.
Pascale RM; Simile MM; De Miglio MR; Muroni MR; Calvisi DF; Asara G; Casabona D; Frau M; Seddaiu MA; Feo F
Hepatology; 2002 Jun; 35(6):1341-50. PubMed ID: 12029619
[TBL] [Abstract][Full Text] [Related]
25. [Inhibitory effect of blocking expression of human augmenter of liver regeneration (hALR) on proliferation of hepatocellular carcinoma cell line HepG2].
Tang L; Sun H; Zhang L; Guo H; Zhang L; Liu Q
Ai Zheng; 2006 Jun; 25(6):671-6. PubMed ID: 16764759
[TBL] [Abstract][Full Text] [Related]
26. Use of RNA interference to target cyclin E-overexpressing hepatocellular carcinoma.
Li K; Lin SY; Brunicardi FC; Seu P
Cancer Res; 2003 Jul; 63(13):3593-7. PubMed ID: 12839946
[TBL] [Abstract][Full Text] [Related]
27. Loss of 9p leads to p16INK4A down-regulation and enables RB/E2F1-dependent cell cycle promotion in gastrointestinal stromal tumours (GISTs).
Haller F; Löbke C; Ruschhaupt M; Cameron S; Schulten HJ; Schwager S; von Heydebreck A; Gunawan B; Langer C; Ramadori G; Sültmann H; Poustka A; Korf U; Füzesi L
J Pathol; 2008 Jul; 215(3):253-62. PubMed ID: 18438954
[TBL] [Abstract][Full Text] [Related]
28. Mechanisms of anti-proliferative effect of JTE-522, a selective cyclooxygenase-2 inhibitor, on human liver cancer cells.
Nagahara T; Okano J; Murawaki Y
Oncol Rep; 2007 Nov; 18(5):1281-90. PubMed ID: 17914586
[TBL] [Abstract][Full Text] [Related]
29. Silibinin efficacy against human hepatocellular carcinoma.
Varghese L; Agarwal C; Tyagi A; Singh RP; Agarwal R
Clin Cancer Res; 2005 Dec; 11(23):8441-8. PubMed ID: 16322307
[TBL] [Abstract][Full Text] [Related]
30. [Inhibitory effects of transcription factor E2F-1 siRNA on invasion and proliferation of gastric cancer cell line MGC803].
Yin YS; Xiao Q; Xie YB; Li L; Wang CQ; Ma YL; Tang ZY
Ai Zheng; 2008 Sep; 27(9):914-8. PubMed ID: 18799027
[TBL] [Abstract][Full Text] [Related]
31. HOXA7 stimulates human hepatocellular carcinoma proliferation through cyclin E1/CDK2.
Li Y; Yang XH; Fang SJ; Qin CF; Sun RL; Liu ZY; Jiang BY; Wu X; Li G
Oncol Rep; 2015 Feb; 33(2):990-6. PubMed ID: 25501982
[TBL] [Abstract][Full Text] [Related]
32. Down-regulation of cyclin E1 expression by microRNA-195 accounts for interferon-β-induced inhibition of hepatic stellate cell proliferation.
Sekiya Y; Ogawa T; Iizuka M; Yoshizato K; Ikeda K; Kawada N
J Cell Physiol; 2011 Oct; 226(10):2535-42. PubMed ID: 21792910
[TBL] [Abstract][Full Text] [Related]
33. [Expression of cyclins in hepatocellular carcinoma and its correlation to tumor cell apoptosis].
Peng SH; Yang JF; Xie PP; Deng H; Li H; Feng DY
Ai Zheng; 2005 Jun; 24(6):695-8. PubMed ID: 15946481
[TBL] [Abstract][Full Text] [Related]
34. [VIGILIN involves in regulation of imprinting gene IGF2 and H19 in human hepatocellular carcinoma cell].
Ge YJ; Xie XY; Yang B; Chai XJ; Zhang YC; Qin Y
Sichuan Da Xue Xue Bao Yi Xue Ban; 2009 Sep; 40(5):770-4. PubMed ID: 19950580
[TBL] [Abstract][Full Text] [Related]
35. Terminal differentiation of normal chicken erythroid progenitors: shortening of G1 correlates with loss of D-cyclin/cdk4 expression and altered cell size control.
Dolznig H; Bartunek P; Nasmyth K; Müllner EW; Beug H
Cell Growth Differ; 1995 Nov; 6(11):1341-52. PubMed ID: 8562472
[TBL] [Abstract][Full Text] [Related]
36. SCF(Fbxw7/hCdc4) targets cyclin E2 for ubiquitin-dependent proteolysis.
Klotz K; Cepeda D; Tan Y; Sun D; Sangfelt O; Spruck C
Exp Cell Res; 2009 Jul; 315(11):1832-9. PubMed ID: 19084516
[TBL] [Abstract][Full Text] [Related]
37. MyoD activity upregulates E2F1 and enhances transcription from the cyclin E promoter in differentiating myoblasts lacking a functional retinoblastoma protein.
Tedesco D; Vesco C
Exp Cell Res; 2001 Oct; 269(2):301-11. PubMed ID: 11570822
[TBL] [Abstract][Full Text] [Related]
38. Hammerhead ribozymes targeted against cyclin E and E2F1 cooperate to down-regulate coronary smooth muscle cell proliferation.
Grassi G; Schneider A; Engel S; Racchi G; Kandolf R; Kuhn A
J Gene Med; 2005 Sep; 7(9):1223-34. PubMed ID: 15772936
[TBL] [Abstract][Full Text] [Related]
39. Lysine acetyltransferase GCN5 potentiates the growth of non-small cell lung cancer via promotion of E2F1, cyclin D1, and cyclin E1 expression.
Chen L; Wei T; Si X; Wang Q; Li Y; Leng Y; Deng A; Chen J; Wang G; Zhu S; Kang J
J Biol Chem; 2013 May; 288(20):14510-14521. PubMed ID: 23543735
[TBL] [Abstract][Full Text] [Related]
40. Regulation of cyclin E1 expression in human pluripotent stem cells and derived neural progeny.
Rodríguez Varela MS; Mucci S; Videla Richardson GA; Morris Hanon O; Furmento VA; Miriuka SG; Sevlever GE; Scassa ME; Romorini L
Cell Cycle; 2018; 17(14):1721-1744. PubMed ID: 29995582
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
